How long does 4-AcO-MiPT last?

The total duration of 4-AcO-MiPT via oral is 4 hours to 8 hours. Onset typically occurs within 20 minutes to 1 hour. Peak effects last 1.5 hours to 3 hours.

4-AcO-MiPT — SubstanceWiki

4-AcO-MiPT (4-acetoxy-N-methyl-N-isopropyltryptamine) is a synthetic psychedelic tryptamine and acetylated prodrug of 4-HO-MiPT (miprocin). It belongs to the same structural class as psilocybin — the 4-acylated tryptamine family — but features a methyl and an isopropyl group on the terminal amine rather than psilocybin's two methyl groups. Like other members of this family, it is presumed to be metabolically converted to its 4-hydroxy counterpart (4-HO-MiPT) following ingestion, which then acts at serotonin 5-HT2A receptors to produce psychedelic effects.

Community reports characterize 4-AcO-MiPT as a visually and psychedelically rich compound with a character sometimes described as more "clear-headed" or intellectually stimulating than 4-AcO-DMT. Users note geometric visual phenomena, enhanced pattern recognition, emotional warmth, and a quality of mental clarity that persists at moderate doses. It is frequently described as more manageable than equivalent doses of 4-AcO-DMT, with a somewhat shorter and gentler come-up. Duration is typically 4–6 hours, consistent with the broader 4-AcO compound family.

As with other 4-AcO tryptamines, 4-AcO-MiPT is available primarily through the research chemical market. It is not subject to systematic clinical research, and its safety profile is inferred from structural class membership and accumulated community experience rather than formal study.

How It Feels

The onset of 4-AcO-MiPT arrives like a slow warming from within. Twenty to forty minutes after ingestion, a deep, radiating warmth begins to build in the core of the body, spreading outward through the limbs in soft waves. The warmth is not merely thermal — it carries an emotional quality, a sense of comfort and safety that softens the edges of anxiety and self-consciousness. There may be mild nausea in the first half hour, but it usually passes quickly, replaced by a pleasant heaviness in the limbs and a tingling in the fingertips and scalp.

As the experience unfolds over the next hour, visual changes begin to emerge. Colors intensify and soften simultaneously — they become more saturated but also warmer, as though the entire visual field has been lit by candlelight. Surfaces develop a gentle breathing quality, expanding and contracting in slow, organic rhythms. Closed-eye visuals are rich and detailed: flowing rivers of warm color, intricate mandala-like structures that pulse with quiet energy, and occasionally vivid, dreamlike scenes that unfold with narrative coherence. There is an introspective pull that is not forced or heavy but rather inviting — the mind turns inward willingly, drawn toward self-examination by curiosity rather than compulsion.

The peak, which arrives around ninety minutes and lasts two to three hours, reveals the compound's most distinctive quality: a warm, enveloping introspection that feels nurturing rather than confrontational. Difficult memories or unresolved emotions may surface, but they arrive wrapped in a compassionate clarity that makes them easier to sit with and examine. The body continues to feel warm and held. Touch becomes deeply pleasurable — not in a stimulated, electric way, but with a slow, intimate tenderness. Music resonates on an emotional level that can bring unexpected tears or quiet joy.

The descent is gentle and extended, the warmth slowly cooling to a pleasant ambient temperature over two to three hours. The introspective depth gradually shallows, leaving behind clear insights and a sense of emotional housekeeping. Physical tiredness arrives softly, and the afterglow carries a quality of tender openness — the world feels a little more beautiful, a little more worthy of attention, and the self feels a little more understood.

Subjective Effects

The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.

Physical Effects

Physical(10)

Excessive yawning— Involuntary, repeated yawning that occurs far more frequently than normal and often without the usua...
Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
Runny nose— Excessive nasal discharge commonly occurring during opioid withdrawal or from nasal irritation cause...
Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Watery eyes— Excessive tear production causing overflow tearing and blurred vision, commonly occurring during opi...

Tactile(1)

Spontaneous tactile sensations— Unprompted physical sensations that arise without external touch or stimulus, manifesting as tinglin...

Cognitive & Perceptual Effects

Visual(16)

After images— A visual phenomenon in which a faint, ghostly imprint of a previously viewed image persists in the v...
Brightness alteration— Perceived increase or decrease in environmental brightness beyond actual illumination levels, common...
Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
Colour shifting— The visual experience of colors on objects and surfaces cycling through continuous, fluid transforma...
Depth perception distortions— Alterations in how the distance of objects within the visual field is perceived, causing layers of s...
Diffraction— The experience of seeing rainbow-like spectrums of color and prismatic halos embedded within bright ...

Detection Methods

Urine Detection

4-AcO-MiPT is not targeted by standard immunoassay-based urine drug screens. As a prodrug, 4-AcO-MiPT is rapidly hydrolyzed in vivo to its corresponding 4-HO (psilocin-type) metabolite, and it is primarily this metabolite that would be detected in biological specimens. Specialized LC-MS/MS methods can detect 4-substituted tryptamine metabolites in urine for approximately 24 to 48 hours after ingestion. The detection window is relatively short compared to many other drug classes due to the rapid hepatic metabolism and renal clearance of tryptamine compounds. Psilocin (4-HO-DMT) is the most commonly targeted analyte in specialized tryptamine panels, and structural analogs may or may not be captured depending on the specific method.

Blood and Serum Detection

Blood detection windows for 4-AcO-MiPT are short, typically 4 to 12 hours after oral ingestion. Peak plasma concentrations of the active metabolite occur within 1 to 2 hours. The rapid first-pass metabolism means that parent compound concentrations in blood are often negligible for 4-AcO prodrugs, while 4-HO compounds themselves are measured directly. LC-MS/MS is required for reliable serum detection at the low concentrations involved.

Standard Drug Panel Inclusion

4-AcO-MiPT is NOT included on standard 5-panel, 10-panel, or 12-panel drug screens. Tryptamines do not cross-react with immunoassay targets for any of the standard panel analytes (amphetamines, cannabinoids, cocaine metabolites, opiates, PCP, benzodiazepines, or barbiturates). Detection requires a specific request for tryptamine or novel psychoactive substance testing at a reference laboratory. Some extended forensic panels include psilocin, which may capture certain 4-substituted tryptamines, but this coverage is not guaranteed for all structural variants.

Confirmatory Methods

Confirmatory identification of 4-AcO-MiPT relies on LC-MS/MS with reference standards specific to the compound or its expected metabolites. GC-MS can also be used following appropriate derivatization. Immunoassay-based methods for psilocybin and psilocin exist but show variable cross-reactivity with structural analogs and are not considered reliable for novel 4-substituted tryptamines. Reference laboratories specializing in novel psychoactive substances offer the most comprehensive detection capabilities.

Reagent Testing (Harm Reduction)

The Ehrlich reagent is the primary harm reduction tool for 4-AcO-MiPT. A sample placed on the reagent should produce a purple to violet color change, confirming the presence of an indole ring system characteristic of tryptamines. This reaction is shared with LSD, psilocybin, DMT, and all indole-containing compounds, so it confirms the general class but not the specific identity. The Hofmann reagent provides a confirmatory blue to violet reaction for tryptamines. The Marquis reagent typically shows no reaction or a dark brown discoloration with 4-substituted tryptamines. A positive Ehrlich result significantly reduces the probability that the substance is a dangerous substitute such as an NBOMe compound.

Interactions

Substance	Status	Note
3-FMA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-MMC	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
8-Chlorotheophylline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Adrafinil	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Anandamide	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
APICA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Atropa belladonna	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Benzydamine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Bromantane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabidiol	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Datura	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Dichloropane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Diphenhydramine	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Ephedrine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Harmala alkaloid	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Hexedrone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methcathinone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Nicotine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Oxiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Peganum harmala	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Phenylpiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabis	Uncertain	—
1,3-Butanediol	Low Risk & Synergy	Cross-tolerance exists; effects compound
25E-NBOH	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-2	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-21	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-7	Low Risk & Synergy	Cross-tolerance exists; effects compound
3-Cl-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCMo	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
4-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
Allylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ayahuasca	Low Risk & Synergy	Cross-tolerance exists; effects compound
Deschloroketamine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Diphenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
DOM	Low Risk & Synergy	Cross-tolerance exists; effects compound
DPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
Efavirenz	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ephenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
EPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
HXE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Ibogaine	Low Risk & Synergy	Cross-tolerance exists; effects compound
Inhalants	Low Risk & Synergy	Produces unique synergistic effects; often combined
Memantine	Low Risk & Synergy	Produces unique synergistic effects; often combined
MET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Methallylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
MiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MXiPr	Low Risk & Synergy	Produces unique synergistic effects; often combined
O-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Psilocybin Mushrooms	Low Risk & Synergy	Cross-tolerance exists; effects compound
Lorazepam	Low Risk & Decrease	Depressants dull psychedelic effects; benzodiazepines are commonly used as trip-killers

Showing 60 key interactions out of 79 total.

Toxicity & Safety

Acute Toxicity

No formal toxicological data in humans. Based on class membership and community experience, acute physiological toxicity at psychedelic doses is presumed low, consistent with the broader 4-hydroxy tryptamine family.

Physiological Effects

Mild sympathomimetic effects standard to the tryptamine class: mydriasis, mild tachycardia, possible nausea during onset. The nausea with 4-AcO-MiPT is generally described as less prominent than with some other tryptamines, though this varies individually. Temperature dysregulation (alternating warmth and chills) is commonly reported during onset.

Psychological Risks

Anxiety and difficult experiences — Less commonly reported than with stronger, longer tryptamines, but possible especially at higher doses or in poorly prepared settings.
Cognitive impairment — Decision-making, memory, and coordination are significantly impaired during the experience; planning for this is essential.
Psychosis risk — Standard contraindication for psychotic or bipolar I disorders applies.

Drug Interactions

MAOIs — Potentiation; serotonin syndrome risk; contraindicated.
Lithium — Seizure risk; contraindicated.
Cannabis — Unpredictable intensity amplification.
Stimulants — Increased cardiovascular stress and anxiety.

Addiction Potential

not habit-forming

Overdose Information

Fatal overdose from 4-AcO-MiPT alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.

However, psychological emergencies can occur and require appropriate response:

Severe anxiety, panic, or psychotic episodes
Dangerous behavior due to impaired reality testing
Self-harm in the context of a distressing experience

Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.

Full	almost immediately after ingestion
Half	3 days
Zero	7 days

4-AcO-MiPT

Quick Dosage

Dosage

oral

Duration

oral

How It Feels

Subjective Effects

Physical Effects

Physical(10)

Tactile(1)

Cognitive & Perceptual Effects

Visual(16)

Pharmacology

Prodrug Conversion

5-HT2A Partial Agonism

Additional Targets

Pharmacokinetics

Detection Methods

Urine Detection

Blood and Serum Detection

Standard Drug Panel Inclusion

Confirmatory Methods

Reagent Testing (Harm Reduction)

Interactions

History

Origins

Research Chemical Era

Community Documentation

Harm Reduction

Source and Verify

Dosing

Set and Setting

Difficult Experiences

After the Experience

Toxicity & Safety

Acute Toxicity

Physiological Effects

Psychological Risks

Drug Interactions

Addiction Potential

Overdose Information

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (3)

See Also

Similar by Effects

Same Class

References (4)

Frequently Asked Questions

Cognitive(13)

Auditory(3)

Multi-sensory(1)

Transpersonal(4)